InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: EDMGUY post# 244

Monday, 07/16/2018 7:00:43 PM

Monday, July 16, 2018 7:00:43 PM

Post# of 796
nothing has changed

https://www.fdatracker.com/fda-calendar/

Oct 5th
VSTM VERASTEM, INC. PDUFA
WhenFriday, Oct 5, 2018
Description2018-10-05 Verastem Oncologys New Drug Application (NDA) requesting the full approval of duvelisib for the treatment of patients with relapsed or refractory CLL/SLL, and accelerated approval for the treatment of patients with relapsed or refractory follicular lymphoma (FL) was accepted for filing by the U.S. Food and Drug Administration (FDA), granted Priority Review and assigned a target action date of October 5, 2018. http://www.businesswire.com/news/home/20180702005288/en/Verastem-Oncology-Participate-Oppenheimer-Boston-Oncology-Insight
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VSTM News